What is Abdallah El-Habr's NPI number?

Abdallah El-Habr's National Provider Identifier (NPI) is 1689767915, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Abdallah El-Habr's specialty?

Abdallah El-Habr is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).

Where is Abdallah El-Habr located?

Abdallah El-Habr's practice location on file with NPPES is 4129 N Armenia Ave Ste B, Tampa, FL 33607-6436.

What is Abdallah El-Habr's phone number?

The practice phone number listed in the NPPES registry for Abdallah El-Habr is (813) 879-3699.

Does Abdallah El-Habr accept Medicare?

Abdallah El-Habr is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Abdallah El-Habr's NPI active?

Yes — Abdallah El-Habr's NPI (1689767915) is active in the NPPES registry as of the last update on 2025-08-13.

IndividualActiveAccepts Medicare

Abdallah El-Habr

NPI 1689767915 · Pulmonary Disease Physician · Tampa, FL

Abdallah El-Habr is a Pulmonary Disease Physician provider in Tampa, FL (NPI 1689767915).

Provider details

NPI number: 1689767915
Entity type: Individual
Primary specialty: Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
Sex: Male
Sole proprietor: No
License: ME171368 (FL)

Practice location

4129 N Armenia Ave Ste B

Tampa, FL 33607-6436

Phone: (813) 879-3699

Fax: (813) 873-8469

Street-level locationGet directions

More FL providers

Mailing address

4129 N Armenia Ave Ste B

Tampa, FL 33607-6436

Specialties & taxonomies

Pulmonary Disease PhysicianPrimary207RP1001XLicense ME171368 (FL)
Allopathic & Osteopathic Physicians
Critical Care Medicine (Internal Medicine) Physician207RC0200XLicense ME171368 (FL)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(84/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,684 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233	319	$119
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232	188	$79
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	176	$131
Critical Care, First 30-74 Minutes99291	153	$213
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	130	$93
Initial Hospital Care With Straightforward Or Low-Level Medical Decision Making, If Using Time, at Least 55 Minutes99222

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 29 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	470	148
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	385	76
Fluticasone/Vilanterolbrand: Breo Ellipta	260	58
Montelukast Sodium	189	65
Fluticasone Propion/Salmeterolbrand: Fluticasone-Salmeterol	116	28
Umeclidinium Brm/Vilanterol Trbrand: Anoro Ellipta	103

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$522 across 25 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-09-30
Last updated: 2025-08-13
Certified: 2025-08-13

Frequently asked questions

What is Abdallah El-Habr's NPI number?: Abdallah El-Habr's National Provider Identifier (NPI) is 1689767915, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Abdallah El-Habr's specialty?: Abdallah El-Habr is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).
Where is Abdallah El-Habr located?: Abdallah El-Habr's practice location on file with NPPES is 4129 N Armenia Ave Ste B, Tampa, FL 33607-6436.
What is Abdallah El-Habr's phone number?: The practice phone number listed in the NPPES registry for Abdallah El-Habr is (813) 879-3699.
Does Abdallah El-Habr accept Medicare?: Abdallah El-Habr is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Abdallah El-Habr's NPI active?: Yes — Abdallah El-Habr's NPI (1689767915) is active in the NPPES registry as of the last update on 2025-08-13.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233	319	$119
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232	188	$79
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	176	$131
Critical Care, First 30-74 Minutes99291	153	$213
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	130	$93
Initial Hospital Care With Straightforward Or Low-Level Medical Decision Making, If Using Time, at Least 55 Minutes99222

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 29 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	470	148
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	385	76
Fluticasone/Vilanterolbrand: Breo Ellipta	260	58
Montelukast Sodium	189	65
Fluticasone Propion/Salmeterolbrand: Fluticasone-Salmeterol	116	28
Umeclidinium Brm/Vilanterol Trbrand: Anoro Ellipta	103

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$522 across 25 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments